IGC PHARMA, INC. Accounts Payable
IGC PHARMA, INC. (IGC) had Accounts Payable of $1.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $1.62M.
- 2026-03-31: Accounts Payable, Current $1.25M.
- 2025-12-31: Accounts Payable, Current $1.01M.
- 2025-09-30: Accounts Payable, Current $628.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.62M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.01M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $628.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $933.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $883.00K 10-KT · filed 2026-03-18 |
| 2024-12-31 | $835.00K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $768.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $771.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $773.00K 10-K · filed 2025-06-27 |
| 2023-12-31 | $648.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $549.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $672.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $530.00K 10-K · filed 2024-06-24 |
| 2022-12-31 | $466.00K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $456.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $456.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $981.00K 10-K · filed 2023-07-07 |
| 2021-12-31 | $357.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $418.00K 10-Q · filed 2021-10-29 |
| 2021-06-30 | $567.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $476.00K 10-K · filed 2022-06-23 |
| 2020-12-31 | $875.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $975.00K 10-Q · filed 2020-11-20 |
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-19 |
| 2020-03-31 | $762.00K 10-K · filed 2021-06-14 |
| 2019-12-31 | $599.00K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $903.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $568.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $319.00K 10-K · filed 2020-07-13 |
| 2018-03-31 | $258.00K 10-K · filed 2019-06-14 |
| 2014-06-30 | $297.15K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $133.37K 10-Q · filed 2014-08-14 |
| 2013-12-31 | $577.88K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $587.02K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $615.39K 10-Q · filed 2013-08-16 |
| 2013-03-31 | $600.70K 10-K · filed 2014-07-15 |
| 2012-12-31 | $291.90K 10-Q · filed 2013-02-13 |
| 2012-09-30 | $367.25K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $316.48K 10-Q/A · filed 2012-08-21 |
| 2012-03-31 | $337.14K 10-K · filed 2014-07-15 |
| 2011-12-31 | $998.56K 10-Q · filed 2012-02-16 |
| 2011-09-30 | $1.17M 10-Q · filed 2011-11-18 |
| 2011-06-30 | $1.58M 10-Q · filed 2011-08-18 |
| 2011-03-31 | $1.31M 10-K · filed 2012-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |